Form 4: Orthopediatrics Corp. CEO David R. Bailey Sells Shares to Cover Tax Obligations

Orthopediatrics Corp.'s CEO, David R. Bailey, sold 3,213 shares of common stock on March 11, 2024, to satisfy tax withholding obligations related to vesting restricted shares.

Summary

• On March 11, 2024, David R. Bailey, the President and CEO of Orthopediatrics Corp., sold 3,213 shares of the company's common stock.
• The sale was executed at a price of $27.59 per share.
• This transaction was conducted to cover tax withholding obligations arising from the vesting of restricted shares.
• Following the transaction, Bailey directly owns 139,384 shares of Orthopediatrics Corp., which includes 59,535 restricted stock awards.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction for tax purposes and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine Form 4 filing, indicating insider transactions. It's common for executives to sell shares to cover tax obligations when restricted stock vests. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the explanation provided (tax obligations) mitigates this concern.

Key Dates